In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to HFA Silver & Gold Members, Fellows of the ESC and Young combined Members

The optimize-heart failure care program in our heart institute in Vietnam

Session Poster Session 2

Speaker Thi Nam Phuong Do

Event : Heart Failure 2019

  • Topic : heart failure
  • Sub-topic : Chronic Heart Failure – Treatment
  • Session type : Poster Session

Authors : PHUONG Do Thi Nam (Ho Chi Minh city,VN), HUAN Do Quang (Ho Chi Minh city,VN), BAN Ha Ngoc (Ho Chi Minh city,VN), DUNG Do Van (Ho Chi Minh city,VN), M R Cowie (Ho Chi Minh city,VN), HAO Do Thi (Ho Chi Minh city,VN), THANH Nguyen Chi (Ho Chi Minh city,VN), HANG Nguyen Thi Thuy (Ho Chi Minh city,VN), DUC Nguyen Huu (Ho Chi Minh city,VN), TIEN Nguyen Thi Tuyen (Ho Chi Minh city,VN), LAN Dang Le Thuy (Ho Chi Minh city,VN), TRANG Tran Kieu Diem (Ho Chi Minh city,VN), DEP Le Thi (Ho Chi Minh city,VN), THU Phan Thanh (Ho Chi Minh city,VN)

Authors:
PHUONG Do Thi Nam1 , HUAN Do Quang1 , BAN Ha Ngoc1 , DUNG Do Van2 , M R Cowie1 , HAO Do Thi1 , THANH Nguyen Chi1 , HANG Nguyen Thi Thuy1 , DUC Nguyen Huu1 , TIEN Nguyen Thi Tuyen1 , LAN Dang Le Thuy1 , TRANG Tran Kieu Diem1 , DEP Le Thi1 , THU Phan Thanh1 , 1Heart Institute - Ho Chi Minh city - Viet Nam , 2Medecine and Pharmacy University - Ho Chi Minh city - Viet Nam ,

Citation:

Our heart institute in Vietnam taken part in the Optimize Heart Failure (OHF) program since October 2016. The aims of this program are to improve patients outcomes by improving heart failure (HF) patients’ awareness of their condition, and by optimizing HF treatment according to a locally-agreed guidelines (based on the ESC guidelines) with checklists to improve guideline adherence in hospital and at subsequent clinic review.

All HF patients with left ventricular ejection fraction < 50% hospitalized in our Institute have been included in the program since October 2016. The patients received education about diet, exercise, weight control and the detection of worsening HF symptoms at home, and HF treatments. All patients were reviewed at 2 months (M2) and 6 months (M6) for clinical signs, treatments and outcomes (readmission and death at 30 days, 60 days and 6 months after discharge). We also performed a telephone survey at 6 months after discharge to check their knowledge and their self-management on the four education topics. The start-up step (basic program) enrolled 401 patients (October 2016 and November 2017) and the full program has enrolled 211 patients to date (Jun 2018-November 2018). All patients were treated according to the same protocol but the full program also included reinforcement of patient education and practitioner guideline adherence.

Data will be presented to show our real word evidence: an improvement of knowledge and practice of HF patients in all of the 4 education themes and an improvement in pharmaceutical prescription rate (including renin-angiotensin-aldosterone system inhibitors, beta-blockers, mineralocorticoid receptor antagonist, and ivabradine for HF patients with NYHA II-IV and sinus rhythm). The rate of readmission and the mortality at 30 days and at 60 days after discharge were also improved with the full program compared with the basic program.

Conclusion: Pharmaceutical guideline adherence has been improved in Vietnam by using simple checklists and regular hospital educational meetings for healthcare professionals. Educational reinforcement helps patients retain information and to follow lifestyle and medical advice. The OHF Care Program is simple, inexpensive, and easy to implement in our country, and may well be easy to implement in other developing countries.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are